Key facts for J7501
- Billing unit
- 100 MG
- Azathioprine parenteral
- OPPS payment rate
- $240.484
- no ASP limit; SI K, October 2026
- Practitioner MUE
- 1
- MAI 3
- NCCI exposure
- no PTP pairs
- Coverage articles
- 0
- none list this code
TL;DR
HCPCS J7501 is the Level II code for Azathioprine, parenteral, 100 mg, billed per 100 MG. CMS publishes no ASP payment limit for it; hospital outpatient departments are paid separately under OPPS (status indicator K, $240.484 per billing unit in October 2026). The practitioner MUE allows up to 1 units per date of service (MAI 3). J7501 is billed in units of 100 MG; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. Other HCPCS codes whose descriptor names azathioprine: J7500 (oral route; billed per 50 mg). The OPPS crosswalk maps 1 NDC to it, sold as Azathioprine by Hikma Pharmaceuticals USA Inc. No current Billing and Coding Article lists J7501, so coverage follows the FDA label, compendia and any applicable NCD.
Medicare payment: OPPS rate (no ASP limit)
J7501 does not appear in the October 2026 Part B ASP payment limit file. CMS pays it separately to hospital outpatient departments under OPPS with status indicator K in APC 0887, at a national unadjusted rate of $240.484 per 100 MG. Status K is a separately paid, non-pass-through drug or biological, including therapeutic radiopharmaceuticals. In a physician office the Medicare contractor prices the drug, often from invoice; commercial and Medicaid payers set their own rates.
NDC to HCPCS billing-unit conversion
The October 2026 OPPS crosswalk maps 1 NDC from 1 labeler to J7501. Report the NDC in the claim's drug segment and bill the number of J7501 units that equals the quantity administered divided by 100 MG; the last column gives units per full package.
| NDC | Drug name | Labeler | Package size | Billing units / package |
|---|---|---|---|---|
| 00143-9566-01 | Azathioprine | Hikma Pharmaceuticals USA Inc. | 1 × 1 | 1 |
Medically Unlikely Edits (MUE)
CMS publishes 3 MUE values for J7501. For practitioners the limit is 1 unit per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.
| Setting | MUE (units/DOS) | MAI | CMS rationale |
|---|---|---|---|
| Practitioner services | 1 | 3 Date of Service Edit: Clinical | Clinical: CMS Workgroup |
| Facility outpatient hospital | 8 | 3 Date of Service Edit: Clinical | Prescribing Information |
| DME supplier | 8 | 3 Date of Service Edit: Clinical | Clinical: CMS Workgroup |
MUE for J7501 in every setting opens the lookup with this code filled in, next to any other code on the same claim.
NCCI edits and add-on relationships
No active practitioner PTP pair lists J7501 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.
The counts above are exposure, not answers for a specific claim. Check J7501 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.
J7501 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.
Medicare coverage articles
No current Billing and Coding Article lists J7501 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.
Local coverage policies that list J7501
1 active Local Coverage Determination lists J7501 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.
- Immunosuppressive Drugs (L33824) · CGS Administrators, LLC; Noridian Healthcare Solutions, LLC
Hospital outpatient (OPPS) status
In the October 2026 OPPS Addendum B, J7501 carries status indicator K and is assigned to APC 0887, with a published national unadjusted payment of $240.484. Status K means the drug is paid separately under OPPS rather than packaged into the procedure.
Ambulatory surgical center (ASC) payment
In the October 2026 ASC Addendum BB (covered ancillary services), J7501 carries payment indicator K2, which CMS defines as "Drugs, biologicals, and radiopharmaceuticals paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS rate". The national ASC payment is $240.48 per 100 MG, paid only when the drug is furnished integral to a covered surgical procedure.
Common denials for J7501 and how to prevent them
How QuickIntell checks J7501 before the claim leaves
QuickCode validates the NDC-to-unit conversion against the current OPPS NDC-HCPCS crosswalk, checks units against every published MUE setting and flags PTP and add-on conflicts on the same claim. QuickRCM routes CARC 16, 151 and 50 denials on drug lines with the matching coverage article attached so the appeal starts with evidence.
In QuickIntell research
- J codes by drug name: Every code for the same drug, generic or brand, in one A-Z index.
Frequently asked questions — HCPCS J7501
What does HCPCS code J7501 describe?
J7501 is defined by CMS as "Azathioprine, parenteral, 100 mg". Each billing unit represents 100 MG, so the units reported on the claim must equal the dose administered divided by that unit.
Is J7501 a CPT code?
No. J7501 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as azathioprine; CPT codes are five-character codes maintained by the AMA. On a Part B claim J7501 reports the drug itself in 100 mg units, and the administration is billed on its own line.
What does Medicare pay for J7501 in a hospital outpatient department?
J7501 has no Part B ASP limit; the October 2026 OPPS Addendum B pays it separately under status K, APC 0887, at $240.484 per 100 MG, and ASC Addendum BB gives it payment indicator K2 at $240.48.
How many units of J7501 can be billed per day?
The practitioner Medically Unlikely Edit is 1 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). The facility outpatient MUE is 8. MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Clinical: CMS Workgroup" as the rationale.
Which NDCs map to J7501?
The October 2026 OPPS crosswalk lists 1 NDC from 1 labeler: Azathioprine (Hikma Pharmaceuticals USA Inc.). For example NDC 00143-9566-01 (package size 1) equals 1 billing unit of J7501.
Does J7501 have NCCI bundling edits?
No active practitioner PTP pairs list J7501 as a column-1 or column-2 code in the v323r0 release.
J7501 vs J7500: what is the difference?
Both are HCPCS Level II codes whose descriptor names azathioprine. What sets J7500 apart: oral route; billed per 50 mg. J7501 is billed per 100 mg, OPPS rate $240.484, MUE 1; J7500 is billed per 50 mg, limit $0.103, MUE 0. Report the code whose descriptor matches the product and setting in the record.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-10. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- HCPCS Level II alpha-numeric file, October 2026Version October 2026 · effective 2026-10-01 · file HCPC2026_OCT_ANWEB_09232026.txtSHA-256 c25240c63108756d…
- OPPS Addendum B, October 2026Version October 2026 · effective 2026-10-01 · file 508-compliant-version-2026_October_Web_Addendum_B.09.28.26.csvSHA-256 6ad7393a318bf1b9…
- OPPS NDC-HCPCS crosswalk, October 2026Version October 2026 · effective 2026-10-01 · file section 508 version of October 2026 OPPS NDC-HCPCS Crosswalk 090426.csvSHA-256 167efe9e47c42718…
- NCCI MUE table, practitioner services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_PractitionerServices_Eff_10-01-2026.csvSHA-256 ef038efaf902b7bd…
- NCCI MUE table, facility services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_OutpatientHospitalServices_Eff_10-01-2026.csvSHA-256 3af9f4e99cc587e2…
- NCCI MUE table, dme services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_DMESupplierServices_Eff_10-01-2026.csvSHA-256 6fa4fbba852f7b74…
- NCCI PTP edits, practitioner, v323r0 (four files)Version v323r0 (2026 Q4) · effective 2026-10-01 · file ccipra-v323r0-f1.TXTSHA-256 7793c0b6686c1e22…
- NCCI Add-On Code edits, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file AOC_V2026Q4-F-MCR.xlsxSHA-256 eabb519623134549…
- ASC Addendum BB (covered ancillary services), October 2026Version October 2026 · effective 2026-10-01 · file Oct 2026 ASC BB.txtSHA-256 63cdd7c72aba7a25…
- Medicare Coverage Database, current Billing and Coding Articles exportVersion MCD release 2026-10-08 · effective 2026-10-04 · file article.csvSHA-256 5e95c4a8ac3664be…
Disclaimer
This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.